OneMedNet Corporation ONMD
0.65
(0.06)
(8.45%)
as of 25 Sep
- Market cap
- $41.8M
- P/E
- 0.0×
Follow ONMD
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
115.87 | 36.06 | 35.67 | 28.31 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(32.83) | (28.61) | (30.49) | (21.97) | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
118.73 | 35.97 | 36.08 | 28.55 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(7.55) | (6.52) | (6.61) | (6.04) | |
EV/FCF |
(7.51) | (6.50) | (6.60) | (6.03) | |
Quick Ratio |
0.27 | 0.33 | 0.19 | 0.22 | |
Current Ratio |
0.29 | 0.43 | 0.27 | 0.28 | |
Net Debt/EBITDA |
0.16 | 0.04 | (0.21) | (0.15) | |
Debt/Assets |
25.76% | 45.28% | 55.54% | 51.39% | |
Debt/Equity |
(0.10) | (0.33) | (0.21) | (0.20) | |
Asset Turnover |
0.17 | 0.46 | 0.81 | 0.79 | |
Operating CF/Net income |
2.36 | 0.55 | 0.63 | 0.86 | |
Capex/Depreciation |
0.00 | (0.56) | (0.18) | (1.80) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
182.49% | 51.91% | 323.96% | 110.96% | |
Selling, General and Administrative Expense of Revenue |
954.80% | 322.13% | 1,938.54% | 469.86% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
80.23% | 166.85% | 448.96% | 158.56% | |
Graham Net Nets |
(0.07) | (0.06) | (0.09) | (0.09) | |
Graham Number |
0.30 | 0.33 | 0.30 | 0.47 | |
Earnings Yield |
(4.96%) | (6.74%) | (6.36%) | (23.11%) | |
Free Cash Flow Yield |
(13.65%) | (15.34%) | (15.32%) | (16.73%) | |
Revenue per Share |
0.00 | 0.02 | 0.00 | 0.01 | |
Operating CF per Share |
(0.03) | (0.04) | (0.03) | (0.03) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.03) | (0.04) | (0.03) | (0.03) | |
Cash per Share |
0.01 | 0.02 | 0.01 | 0.01 | |
Shareholders Equity per Share |
(0.07) | (0.07) | (0.07) | (0.06) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(0.07) | (0.07) | (0.07) | (0.06) | |
Free Cash Flow |
(1.75) | (1.72) | (1.54) | (1.88) | |
Working Capital |
(3.56) | (2.73) | (3.89) | (3.41) | |
Capital Expenditures |
0.00 | 0.00 | 0.00 | (0.01) | |
Net Current Asset Value |
(4.00) | (3.02) | (4.13) | (3.57) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.01 | 0.02 | 0.03 | |
Net Profit Margin |
(418.64%) | (352.81%) | (2,555.21%) | (743.84%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.32 | 0.35 | 0.47 | 0.46 | |
Average Payables |
5.00 | 4.77 | 5.41 | 4.36 | |
Average Assets |
2.95 | 2.94 | 1.62 | 1.85 | |
Average Common Equity |
(9.10) | (9.46) | (10.31) | (3.68) |
Columns are period end dates